How Kappa Opioid Receptors Drive Anxiety – PsychLiverpool
Innovation – Cara Therapeutics
Diverse Kappa Opioid Receptor Agonists: Relationships Between Signaling and Behavior
Opioid receptors | Introduction | BPS/IUPHAR Guide to PHARMACOLOGY
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
Will peripherally restricted kappa‐opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential? - Albert‐Vartanian - 2016 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library
κ-opioid receptor - Wikipedia
Pharmaceuticals | Free Full-Text | Therapeutic Potential of Kappa Opioid Agonists | HTML
Role of Kappa Opioid Receptors in Symptoms of Schizophrenia: What Is the Neurobiology? - Biological Psychiatry
Table II from Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review. | Semantic Scholar
Activation of opioid receptors in the enteric nervous system. MOR mu... | Download Scientific Diagram
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics
Structure of the human κ-opioid receptor in complex with JDTic | Nature
Peripheral Kappa Opioid Receptor Signaling Takes on a Central Role - ScienceDirect
Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion | Semantic Scholar
Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment - ScienceDirect
A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics - ScienceDirect
The role of the opioid system in decision making and cognitive control: A review | SpringerLink
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Nephrology Jrnl Club on Twitter: "Difelikefalin (CR845) (KORSUVA) is a peripherally restricted, selective kappa opioid receptor agonist that exerts antipruritic effects by means of activation of kappa opioid receptors on peripheral neurons
Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain | Journal of Neuroscience
κ-Opioid Receptor (KOP) | 7TM Antibodies
Will peripherally restricted kappa‐opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential? - Albert‐Vartanian - 2016 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library